The Liver Meeting 2020-COVID-19 and Chronic Liver Disease Connecting Patients and Physicians

COVID-19 and Chronic Liver Disease Connecting Patients and Physicians

Video Transcription

Video Summary

The liver meeting digital experience discussed COVID-19 and chronic liver disease, featuring patient experiences and expert insights. Speakers highlighted the impact of the virus on liver disease patients, emphasizing the importance of up-to-date information and patient care. Patients with chronic liver diseases like NAFLD and NASH may face more severe outcomes when infected with COVID-19. Recommendations included maintaining healthy lifestyle habits, continuing treatments, and avoiding alcohol intake. Patients listed for liver transplants should communicate closely with their care teams and consider telemedicine options. Patients with autoimmune hepatitis should continue immunosuppressive treatments. Overall, prevention and adherence to public health guidelines, such as hand hygiene, mask-wearing, and social distancing, are crucial for liver health during the pandemic. The American Association for the Study of Liver Disease (AASLD) developed patient resources focusing on various liver diseases and COVID-19, and patient engagement is a priority for the organization. This program marks a step towards enhancing patient engagement within the liver disease community.

Keywords

liver meeting

COVID-19

chronic liver disease

patient experiences

expert insights

NAFLD

NASH

AASLD